Zimmer CAS, a world leader in computer-assisted surgery solutions, today inaugurated its new production unit in Montréal. Jeff McCaulley, President of the Reconstructive Division of Zimmer Holdings and Dr. Louis-Philippe Amiot, General Manager at Zimmer CAS (formerly OrthoSoft), presented two new technologies at the event that now offer surgeons around the world an unparalleled degree of precision and simplicity for knee and shoulder implant surgery.
“I would like first of all to congratulate and thank our entire development team, which has designed in these past few years some highly sophisticated equipment to construct our new knee navigation technology. This is an electronic microminiaturized system equipped with accelerometers and gyroscopes that make it possible to precisely determine bone-cutting angles in the operating room. A green light indicates when the instrument is properly positioned and the surgeon can immediately confirm that the procedure has been performed correctly,” explained Dr. Amiot.
In the same production unit, Zimmer CAS also produces personalized instruments that are placed directly on the patient’s bones to guide cutting. “This second product is used for knee and shoulder implants. Magnetic resonance imaging (MRI) taken before the surgery enables us to provide the surgeon with an instrument that is perfectly adapted to the patient. The operation is quicker and more precise. This technology complements our current product line-up and enables us to reach a greater number of surgeons,” added Dr. Amiot. “We estimate the number of patients operated since OrthoSoft’s creation in 1996 to be in excess of 125,000—with leading-edge medical instruments that are recognized and sold around the world.”
Also on hand at the inauguration was Élie Farah, Vice President Investment Greater Montréal at Montréal International, who said he was very proud that his team has been able to contribute to this expansion project which has enabled the company to double its workforce. “The success of Zimmer CAS enhances the attractiveness of Greater Montréal and the province of Québec among international life sciences and health technologies industry leaders, and in so doing, fosters the development of a key strategic sector for our region,” said Farah. “Research and innovation are two key components of Greater Montréal’s competitiveness and prosperity.”
With more than 43,000 people employed by some 600 private companies, including 150 public and university research organizations, Greater Montréal’s life sciences and health technologies (LSHT) industry enjoys an international status. Recognized for its top-notch expertise, Greater Montréal’s LSHT industry cluster benefits from the presence of international leaders in pharmaceuticals, biotechnology, contract research and medical technologies, as well as a number of research institutes specializing in basic research in neurology, oncology, cardiology, endocrinology and immunology.
About Zimmer CAS (www.zimmer.com)
A subsidiary of Zimmer Holdings since 2007, Zimmer CAS (formerly OrthoSoft) designs and develops computer-assisted solutions that offer surgeons an unparalleled degree of precision for knee, shoulder and hip implant surgery. Founded in Warsaw, Indiana, in 1927, Zimmer Holdings is a world leader in the musculoskeletal health care industry. The company has offices in 25 countries and employs more than 8,500 people. Its arthroplasty technology and products are sold in some 100 markets. Zimmer had sales of close to $4.5 billion in 2012.